- Home
- ROIV vs NNN Comparison
ROIV vs NNN Comparison
Compare ROIV & NNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ROIV
- NNN
- Stock Information
- Founded
- ROIV 2014
- NNN 1984
- Country
- ROIV United Kingdom
- NNN United States
- Employees
- ROIV N/A
- NNN N/A
- Industry
- ROIV Biotechnology: Pharmaceutical Preparations
- NNN Real Estate Investment Trusts
- Sector
- ROIV Health Care
- NNN Real Estate
- Exchange
- ROIV Nasdaq
- NNN Nasdaq
- Market Cap
- ROIV 7.8B
- NNN 7.8B
- IPO Year
- ROIV N/A
- NNN N/A
- Fundamental
- Price
- ROIV $11.40
- NNN $43.24
- Analyst Decision
- ROIV Buy
- NNN Hold
- Analyst Count
- ROIV 4
- NNN 10
- Target Price
- ROIV $17.50
- NNN $45.11
- AVG Volume (30 Days)
- ROIV 7.9M
- NNN 1.0M
- Earning Date
- ROIV 08-07-2025
- NNN 08-05-2025
- Dividend Yield
- ROIV N/A
- NNN 5.38%
- EPS Growth
- ROIV N/A
- NNN N/A
- EPS
- ROIV N/A
- NNN 2.14
- Revenue
- ROIV $29,053,000.00
- NNN $884,713,000.00
- Revenue This Year
- ROIV $3.28
- NNN $4.76
- Revenue Next Year
- ROIV $156.84
- NNN $4.03
- P/E Ratio
- ROIV N/A
- NNN $20.17
- Revenue Growth
- ROIV N/A
- NNN 5.40
- 52 Week Low
- ROIV $8.73
- NNN $35.80
- 52 Week High
- ROIV $13.06
- NNN $49.57
- Technical
- Relative Strength Index (RSI)
- ROIV 54.55
- NNN 55.31
- Support Level
- ROIV $10.71
- NNN $42.41
- Resistance Level
- ROIV $11.58
- NNN $43.45
- Average True Range (ATR)
- ROIV 0.29
- NNN 0.64
- MACD
- ROIV 0.00
- NNN -0.06
- Stochastic Oscillator
- ROIV 62.16
- NNN 48.68
About ROIV Roivant Sciences Ltd.
Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.
About NNN NNN REIT Inc.
NNN REIT Inc is a real estate investment trust that invests in and develops properties throughout the United States. The company generates revenue from leasing properties to tenants, including convenience stores, automotive services, fitness centers, theatres, restaurants, and banks. Rents from convenience stores and restaurants contribute the majority proportion of total revenue. The maximum of the company's properties are located in the South and Southeast of the United States.